The FDA has approved the Izun Pharmaceuticals’ 510(k) application for Curasite™ Wound Care Hydrogel. Curasite™ is a proprietary topical combination of three botanical extracts: Centella asiatica, Echinacea purpurea and Sambucus nigra in a hydrogel base.
The prescription indications approved for use include the treatment of:
- Diabetic foot ulcers
- Leg ulcers, including venous stasis ulcers, arterial ulcers and ulcers of mixed etiology
- Full and partial thickness pressure ulcers
- 1st and 2nd degree partial thickness burns
The approved over-the-counter indications for use are:
- Minor abrasions
- Minor lacerations
- Minor cuts
- Minor scalds and burns
Izun Pharmaceuticals is based in Jerusalem.
For more information, see: